Jürgen B. Bulitta - Concepedia

Author

Jürgen B. Bulitta

Also Known As

Holden, Patricia N., J BULITTA, J Bulitta, J. B. Bulitta, J. Bulitta, J.B. Bulitta, Juergen B Bulitta, Juergen B. Bulitta, Juergen Bulitta, Jurgen B Bulitta

223

Publications

7.7K

Citations

H-Index

119

Concepts

All Affiliations

Monash University University of Florida University at Buffalo, State University of New York Institute for Biomedical and Pharmaceutical Research Albany Research Institute

About

Jürgen B. Bulitta is an author at Monash University specializing in medicine, pharmacology, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	46	1.7K
2	Health Sciences	17	20	947
3	Engineering	5	5	272
4	Natural Sciences	1	1	15
5	Public Health	1	1	23

Jürgen B. Bulitta

133

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetic/Pharmacodynamic Investigation of Colistin against <i>Pseudomonas aeruginosa</i> Using an <i>In Vitro</i> Model Phillip J. Bergen, Jürgen B. Bulitta, Alan Forrest, Antimicrobial Agents and Chemotherapy	2010	165
Population Pharmacokinetics and Pharmacodynamics of Continuous versus Short-Term Infusion of Imipenem-Cilastatin in Critically Ill Patients in a Randomized, Controlled Trial Samir G. Sakka, Anna K. Glauner, Jürgen B. Bulitta, Antimicrobial Agents and Chemotherapy	2007	152
Attenuation of Colistin Bactericidal Activity by High Inoculum of<i>Pseudomonas aeruginosa</i>Characterized by a New Mechanism-Based Population Pharmacodynamic Model Jürgen B. Bulitta, Jenny C. Yang, Liliana Yohonn, Antimicrobial Agents and Chemotherapy	2010	134
Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid Lauren Boak, Craig R. Rayner, M. Lindsay Grayson, Antimicrobial Agents and Chemotherapy Platelet NadirsPharmacotherapyAntimicrobial ChemotherapyPharmacodynamic ModelingDrug Resistance	2014	122
Development of a New Pre- and Post-Processing Tool (SADAPT-TRAN) for Nonlinear Mixed-Effects Modeling in S-ADAPT Jürgen B. Bulitta, Beom Soo Shin, Cornelia B. Landersdorfer The AAPS Journal New Pre-EngineeringRobust ModelingNonlinear Mixed-effects ModelingSystems Engineering	2011	118
Systematic Comparison of the Population Pharmacokinetics and Pharmacodynamics of Piperacillin in Cystic Fibrosis Patients and Healthy Volunteers Jürgen B. Bulitta, Stephen B. Duffull, M. Kinzig‐Schippers, Antimicrobial Agents and Chemotherapy	2007	118
Phase 2, Randomized, Double-Blind, Dose-Ranging Study Evaluating the Safety, Tolerability, Population Pharmacokinetics, and Efficacy of Oral Torezolid Phosphate in Patients with Complicated Skin and Skin Structure Infections Philippe Prokocimer, Paul Bien, Joseph Surber, Antimicrobial Agents and Chemotherapy Antibiotic AdjuvantPharmacotherapyDermatologyBacterial PathogensDrug Resistance	2010	116
Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model Phillip J. Bergen, Brian T. Tsuji, Jürgen B. Bulitta, Antimicrobial Agents and Chemotherapy	2011	115
Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula Phillip J. Bergen, Alan Forrest, Jürgen B. Bulitta, Antimicrobial Agents and Chemotherapy	2011	114
Evaluation by Monte Carlo Simulation of the Pharmacokinetics of Two Doses of Meropenem Administered Intermittently or as a Continuous Infusion in Healthy Volunteers Wolfgang A. Krueger, Jürgen B. Bulitta, Martina Kinzig‐Schippers, Antimicrobial Agents and Chemotherapy	2005	102

Page 1